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In the early 1980s, physiologically based
pharmacokinetic (PBPK) modeling was
applied to study the disposition ofenviron-
mental chemicals in mammalian systems
(1). Through their implicit biological
descriptions of mammalian systems, these
models provide a functional relationship
between external measures of chemical
exposure and internal target tissue measures
ofexposure to the actual toxic moiety (2).
One ofthe earliest chemicals to be stud-
ied using PBPK modeling was methylene
chloride (1,2-dichloromethane, CH2C12)
(3). Based on computer simulation, the a
priori predictions of blood concentrations
were consistent with actual experimental
results from three laboratories on four differ-
ent species, indudinghumans, via two routes
ofexposure (3). Because ofthe versatility of
the PBPK model and its ability to extrapo-
late among species and routes, Andersen et
al. (3) expanded the analysis by correlating
tumor incidences with target tissue dose
based on the putative mechanisms oftoxicity
from the mixed function oxidase (MFO) and
glutathione S-transferase (GST) metabolic
pathways. Andersen et al. (3) conduded that
the amount metabolized by the GST path-
way correlates best with tumor indices and
that conventional risk analysis techniques
overestimate human risk when exposed to
lowconcentrations ofmethylene chloride.
While PBPK modeling is a powerful
tool for making a priori predictions with
limited experimental data (i.e., based on
educated assumptions), it is important to
challenge the validity of assumptions with
proper experimentation. Since pharmacoki-
netic studies are usually done on young,
healthy untreated animals, the potential
effects of aging and prior exposure (short-
term or chronic) on the kinetic behavior of
a chemical are largely unknown and may
lead to false conclusions when applied to
long-term studies. For example, Yang et al.
(4) described pharmacokinetic studies on
ethylenediamine in Fischer 344 rats that
paralleled a 2-year chronic toxicity/carcino-
genicity study. These investigators observed
an inverse age-related change in volume of
distribution that was attributed to the dis-
proportional increase ofbody fat with age
and the water soluble nature ofethylenedi-
amine. Therefore, even though the dose was
maintained on the same milligram per kilo-
gram basis (according to body weight) as in
conventional toxicology studies, older rats
actually had higher levels ofexposure to the
test chemical due to higher plasma levels of
ethylenediamine (4). Investigations such as
the one reported byYang et al. (4) are useful
in the interpretation of toxicologic findings
of chemicals of interest, particularly in
chronic bioassay studies. Such sentiment is
shared byother investigators in the fieldwho
stress the need to evaluate chemical toxicity
with respect to age andpriorexposure (5-).
In 1988, the National Institute of
Environmental Health Sciences/National
ToxicologyProgram (NIEHS/NTP) initiated
research in which the possible relationships
between tumorigenesis, oncogene activation,
and cell turn-over rates in methylene chlo-
ride-exposed B6C3F1 female mice were
investigated (inhalation route; onegroup only
at 2000 ppm) (8). Much ofthe information
from this research program has been pub-
lished in a series ofpapers in a single issue of
Carcinogenesis (8-13). As an integral part of
this investigation, a pharmacokinetic study
was incorporated to determine the possible
age- and chronic dosing-related kinetic
changes. The pharmacokinetic study was
designed to occur in parallel with the carcino-
genicity studies and enhance the information
derived from the study as a whole. Thus, the
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primary objective ofthis study was to deter-
mine changes in metabolic and solubility
parameters ofmethylene chloride as a func-
tion ofageand chronic exposure.
Materials and Methods
Test Chemical,Animals, and
Chronic Inhalation Exposure
Spectroscopic grade methylene chloride
(>99% purity) was purchased from Burdick
and Jackson Company. B6C3F1 female
(C57B1/6N x C3H/HeN MTV-) mice
were produced under barrier conditions at
Charles River Co. (Portage, MI) under con-
tract to NTP. All animals were 4-6 weeks
ofage upon arrival and housed individually
in H-2000 inhalation chambers (Hazleton
Systems, Inc., Aberdeen, MD) 24 hr/day. A
complete microbiological/virological health
surveillance screening was performed at 6-
month intervals and was negative through-
out the course of the study. Control and
treated animals were given food (NIH-07,
Zeigler Brothers, Inc., Gardners, PA) and
filtered (0.2 pm), UV-irradiated water ad
libitum.
Methylene chloride was vaporized in
nitrogen, diluted with air, and introduced
into whole-body chambers where concen-
trations were monitored with a Miran 80
infrared spectrometer. Mice were exposed
to 2000 ppm methylene chloride during the
day at a regimen of 6 hr/day, 5 days/week
in the chronic toxicology study for 2 years;
control mice were sham-exposed to condi-
tioned HEPA-filtered air. All other infor-
mation concerning animal care and expo-
sure is presented in detail elsewhere (14).
Age- and Chronic Dosing-related
Pharmacokinetic Studies
In the pharmacokinetic study, gas-uptake
experiments (15) were conducted on control
and exposed (2000 ppm methylene chlo-
ride) female mice at 1 dayand 1, 12, and 24
months following initiation ofexposure reg-
imen. At each ofthe designated time points,
24 control or exposed mice from the 1-day
or 1-month group or 12 control or exposed
mice from the 12- or 24-month group were
placed in a 12-liter closed recirculating
exposure system. The differences in num-
bers among different age groups reflect our
attempt to provide equivalent liver mass in
the gas-uptake system for methylene chlo-
ride disposition. Oxygen was added and
maintained at approximately 21% while car-
bon dioxide was removed with a barium
hydroxide scrubber. Methylene chloride was
added in sufficient quantity to achieve a tar-
geted initial chamber concentration and the
atmosphere was serially sampled by an in-
line Hewlett Packard 5890 gas chromato-
graph (Hewlett Packard, Avondale, PA) for
up to 6 hr.
Each group of mice (control or exposed
atvarious timepoints) was exposed to an ini-
tial methylene chloride concentration of500
ppm in the gas-uptake system. After 48 hr,
the same batch ofanimals was again exposed
in the gas-uptake system at an initial concen-
tration of 1000 or 2000 ppm methylene
chloride. Although the primary reason for
such a repeated exposure design was the lim-
ited availability ofanimals within a complex
study design (14), we felt that the initial gas-
uptake studies at 500 ppm would not have a
major impact on the overall pharmacokinetic
experimental outcome for the following rea-
sons: concurrent control animals were treat-
ed identically to exposed animals; the meth-
ylene chloride-treated group was exposed to
2000 ppm for 6 hr/day, 5 days/week, and
pharmacokinetic experiments were conduct-
ed in the latter part ofthe week to allow at
least 2 exposure days prior to pharmacoki-
netic experiments; and 500 ppm is the initial
concentration at time-zero ofthe gas-uptake
experiment, and the concentration in the
chamber decreases rapidly due to disposition
and biotransformation. Thus, the animals
were exposed to lower and lower concentra-
tions ofmethylene chloride, which were not
believed to cause significant physiological
changes as compared to the daily exposures
at 2000 ppm. Further, whatever changes
would occurwouldpresumablybe present in
the concurrent control mice as well. Finally,
due to the short half-life ofmethylene chlo-
ride in the body, it was believed that a 48-hr
resting period would be sufficient for the
clearance ofresidual methylene chloride in
the mouse.
Following the final gas-uptake study,
mice were sacrificed and organ masses such
as liver and lung mass were measured. The
organs and remaining tissues such as mus-
cle and fat were dissected and homogenized
for tissue partition coefficient measure-
ments to examine potential physiological
changes related to disposition. In all studies
conducted in this project, the order of
experimentation was from low to high con-
centrations ofmethylene chloride and from
control to exposed mice.
Determination ofTissue Partition
Coefficients
A modified version ofthe vial equilibration
technique of Sato and Nakajima (16) was
used to determine tissue partition coeffi-
cients for methylene chloride in mice at var-
ious exposure periods on this project
(17,18). Head space analyses ofmethylene
chloride were made using a Hewlett
Packard 5790A GC (Hewlett Packard) with
a flame ionization detector. The column
was 10% SE-30 on Supelcoport 80/100
mesh (10 ft, 1/8 in O.D., S.S.) (Supelco
Inc., Bellefonte, PA) and resulted in an
average retention time of 1.1 min for meth-
ylene chloride. Oven temperature was
isothermal at 80°C while detector and
injector temperatures were maintained at
300° and 125°C, respectively. Flow rates
were as follows: air (390 ml/min), hydrogen
(18 ml/min), and nitrogen (32 mIl/min).
Physiological Pharmacokinetic
Model
The basic methylene chloride model struc-
ture was described by Andersen et al. (3)
(Fig. 1). The body was subdivided into five
tissue groups consisting of the liver, lung,
slowly perfused, rapidly perfused, and fat.
Each compartment was represented by mass
balance differential equations which incorpo-
rate blood flows, partition coefficients, and
tissue volumes. The concentration ofmeth-
ylenechloride inbloodleavingthelungwas
assumed to be in equilibriumwith thecon-
centration in alveolar air as determined by
the blood:air partition coefficient. Methylene
chloride was distributed to all tissues and
eliminated by metabolism in the lung and
liver, aswell as byexhalation.
ci op cx m &K
aC_ (C
cv CA
cmartetswtfo(ndprItincofi
rse CA
CYR < ~~~~~QR
CVF _ aF
aL aL
CVL CA
Figure 1. Diagram of the physiologically based
pharmacokinetic model used for methylene chlo-
ride. Tissues of the body are grouped into five
compartments with flow and partition coeffi-
cients: lung, fat, liver, richly perfused, and slowly
perfused. Methylene chloride enters the body
through inhalation (CX) with absorption into pul-
monary blood in the gas-exchange compartment.
Concentrations of methylene chloride in the
venous blood (CV) and arterial blood (CA) are cal-
culated based on blood flow (QC, QS, QR, (IF, and
QL), alveolar ventilation (QP), and solubility infor-
mation. Exhalation (CX) and metabolic processes,
such as Michaelis-Menton metabolism (V axand
Km) or first-order enzymatic conjugaitionr4lC, are
included for removal of methylene chloride. Loss
from the chamber(KLC) is also accounted for.
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The basic model structure was modified
for a combination of Monte Carlo simula-
tion and bootstrap resampling using a
method described by Thomas et al. (19).
Briefly, a separate program was written to
randomly sample model parameters from
defined distributions or, in the case ofboot-
strapped parameters, resample parameters
with replacement from given data sets. A
total of 1000 values were sampled for each
parameter and stored in a format recognized
by the differential equation solver (SimuSolv
Software, Dow Chemical Co., Midland,
MI). The model was then run for each set of
parameters while the metabolic constants,
V (mixed function oxidase rate constant)
and KC (GST rate constant), were optimized
based on the gas-uptake data using a least-
squares technique. Following optimization,
datavalues were stored forstatistical analysis.
For model stability as well as practical rea-
sons, the sum ofthe individual organ masses
was constrained to be less than the body
mass by setting the volume ofslowly per-
fused tissue equal to the difference between
bodymassandthe remaining tissues.
The Monte Carlo method is a form of
uncertainty analysis that allows the propa-
gation of uncertainty through a model
which results in an estimate ofthe variance
in model output (19). For the uncertainty
analysis, Monte Carlo simulation randomly
samples model parameters from defined dis-
tributions (e.g., normal, lognormal) with
defined central tendencies and variability.
Among parameters sampled using Monte
Carlo simulation, the distributions of car-
diac output, partition coefficients, and
metabolic parameters were assumed to have
lognormal distributions while the remain-
ing parameters were assumed to have nor-
mal distributions (Table 1) (20). Tissue
partition coefficients, as mentioned previ-
ously, were measured for only a subpopula-
tion of the exposure group; therefore, the
parameters used to represent the partition
coefficients were sampled using a Monte
Carlo routine based on the exposure-specif-
ic central tendency and associated uncer-
tainty for each group. Parameters derived
from the literature, such as blood flows and
remaining tissue volumes, were also sam-
pled using Monte Carlo simulation and
assumed to have a standard deviation of
20% with two exceptions: Al and A2 (20).
Parameters Al and A2 represent the Vm.c
and Kfc ratios between the lung and the
liver and were assigned standard deviations
of17 and 12%, respectively (17) (Table 1).
In contrast, bootstrap resampling con-
tinually resamples model parameters from
given data sets and does not assume a given
distribution. This allows parameters such
as body mass, liver mass, and lung mass,
which were measured for all individual
mice, to be constrained to represent only
those mice producing the gas-uptake data.
Due to the lipophilicity of methylene
chloride, thepercent ofbodyweight as fat is
an important parameter in the modeling
process. Consequently, the change ofthe fat
to body weight ratio as a function ofage is
also important. An estimate ofthese values
was based on experimentally determined
data from C57 mice (L. Birnbaum, person-
al communication) and Diliberto et al.
(21). For example, C57 mice at 3 or 18
months of age maintained fat to body
weight ratios of 7 to 14%, respectively. In
our study, the following mean fat to body
weight ratios were used for female B6C3F1
mice at various ages: 4% for 8 weeks (1-day
group), 10% for 12 weeks (1-month
group), 15% for 60 weeks (1-year group),
and 12% for 107weeks (2-yeargroup). The
lower value for the 2-year animals was cho-
sen due to their generally lower body
weight relative to the 1-year animals.
Age-related changes in alveolar ventila-
tion and cardiac outputwere also estimated
based on previous studies in both rats and
mice. According to Pesce et al. (22), carbon
dioxide emissions (VCO2) from female
OF1 mice dropped 23% between the ages
of 30 and 95 days and 57% between 30
and 412 days. Assuming no change in the
partial pressure of alveolar carbon dioxide,
the change in carbon dioxide emissions is
directly proportional to the change in alve-
olar ventilation (23). In our model, an ini-
tial scaled alveolar ventilation of23 1/hr kg
was used for the 1-day group (24).
Accordingly, the 1-month, 1-year, and 2-
year groups were assigned lower ventilation
rates of21, 15, and 15 1/hr kg, respectively.
In contrast to alveolar ventilation for
which rates have been measuredwith age, no
previous studies on age-related changes in
cardiac output for mice were found. This is
due primarily to the invasive nature of the
procedure and the relatively small size of
mice (25). However, using age-related
changes in cardiac output in rats as a model,
Isoyama et al. (26) measured cardiac output
of 10.2, 9.8, and 7.9 1/hr kg in 9, 18, and
22-month-old control rats. Although the
drop between the 9 and 18-month-old rats
was not statistically significant, the decrease
in the 22-month-old rats was significant atp
< 0.05 (26). ThedatabyIsoyamaet al. (26)
suggest an initial plateau ofcardiac output
with age, followed by a dedine in the latter
ages. Accordingly, cardiac output was set in
our model to 16, 16, 15, and 12 I/hr kg for
the 1-day, 1-month, 1-year, and 2-year
groups, respectively.
DataTreatment
Although techniques commonly applied to
toxicologic and pharmacokinetic studies
involve the application of statistics for con-
tinuous and normally distributed popula-
tions, a considerable amount of the opti-
mized metabolic data was such that the
underlying distribution was not easily speci-
Table 1. Model parameters used inthe PBPK/Monte Carlo simulationsfor B6C3F1 mice
PBPK parameter Datatype Mean SD Sample distributions
Weights:
Body(kg) X a a
Lung X a a
Liver X a a
Rapidly perfused L 0.05b 20% Normal
Slowly perfused C
Fat L c 20% Normal
Flows
Alveolar(I/hrkg) L 21 20% Lognormal
Cardiac output(I/hr kg) L
Liver L 0.24d 20% Normal
Rapidly perfused C
Slowly perfused L 0.24d 20% Normal
Fat L 0.05d 20% Normal
Partition coefficients
Tissue/air X e Lognormal
Metabolic constants
Km(mg/I) L 0.4 20% Lognormal
Al L 0.416 0.07 Lognormal
A2 L 0.137 0.016 Lognormal
aExperimental data bootstrapped to representonlythose mice generating gas-uptake data.
bMean given as a percentage ofbodyweight.
CMean variedwith age group.
dMean given as a percentage ofcardiac output.
"Mean and standard deviation varied with study group.
X,experimental observaton; C,calculated; L, literature.
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parametric alternative to a one-way analysis
of variance. Between-group post-tests and
exposed/control comparisons were per-
formed using the Mann-Whitney-Wilcoxon
U test and adjusted using the Bonferroni
adjustment for multiple comparisons (27).
Statistical tests were performed using the
Minitab statistical software package, release
7.2 (Minitab, Inc., State College, PA).
Analysis of the partition coefficients
with respect to age and treatment was per-
formed using both a parametric two-way
analysis of variance and a nonparametric
Table 2. Summary ofbodyand organ weights on B6C3F1 mice used in gas-uptake pharmacokinetic studies"
Organ weight(g)c
Study group No. ofanimals Bodyweight(g)b Liver Lung
1 day Control 24 18.3 ± 1.0 0.87 ± 0.18 0.147 ± 0.019
Exposed 24 18.0 ± 1.0 0.88 ± 0.08 0.139 ± 0.016
1 month Control 24 22.1 ±0.8 1.16± 0.07 0.172±0.020
Exposed 24 22.9 ± 1.1 1.25 ±0.13 0.181 ± 0.022
1 year Control 12 37.8 ±4.9 1.42 ±0.16 0.240 ± 0.030
Exposed 12 38.0 ± 5.6 1.55 ± 0.17 0.253 ± 0.050
2 year Control 12 37.8 ± 4.7 2.00 ± 0.41 0.311 ± 0.055
Exposed 12 36.1 ± 5.4 2.59 ± 0.82 0.344 ± 0.054
aMean ± SD. 'These values represent mean bodyweights atthe beginning ofthe first gas-uptake study in the series.
cThe organ weights at and beyond 12 months include tumor masses.
Table 3. Summary ofvalues for in vivoapparent VmaxC (mg/hr kg)following optimization and Monte Carlo
simulation for B6C3F1 mice exposed to methylene chloride
Standard First/third
Study group Mean Median deviation quartiles Skewness Kurtosis
1 day Control 4.55 4.53** 0.39 4.29, 4.79 0.42 0.24
Exposed 6.46 6.44*# 0.63 6.04, 6.84 0.32 0.70
1 month Control 7.41 7.28** 1.08 6.59, 8.11 0.46 -0.27
Exposed 9.43 9.31* 1.36 8.51, 10.37 0.19 -0.31
1 year Controla b 11.04** b 10.17, 12.05 23.9 640.6
Exposeda b 9.76*1 b 8.56, 10.73 6.82 49.6
2year Control 9.16 9.31** 1.38 8.18,10.17 -0.20 -0.30
Exposed 8.57 8.68*# 1.58 7.34, 9.57 0.36 0.47
aResults should be interpreted with caution due to inability ofmodel to describe gas-uptake data.
bValues not reported due to skewness of results and influence of outliers.
*Statistically significant for control vs. exposed; p < 0.001 (as determined by studygroup).
**Statistically significant between age groups among controls; p< 0.05.
#Statistically significant between age groups among exposed; p< 0.05.
Table 4. Summary ofvalues for in vivo apparentKfc (kg/hr)following optimization and Monte Carlo simula-
tion for B6C3F1 mice exposed to methylene chloride
Standard First/third
Study group Mean Median deviation quartiles Skewness Kurtosis
1 day Control 1.94 1.89** 0.30 1.73, 2.08 1.07 1.41
Exposed 0.99 0.93*# 0.32 0.78,1.16 0.73 0.84
1 month Control 1.13 1.18** 0.41 0.89,1.41 -0.46 0.13
Exposed 0.83 0.89*# 0.52 0.41, 1.17 -0.06 -0.73
1 year Controla b 2.67** b 1.13, 3.15 3.58 33.6
Exposed8 b 3.01* b 2.37, 5.14 6.85 49.9
2year Control 0.11 0.03** 0.16 0.01, 0.18 1.85 3.91
Exposed 0.32 0.32*4 0.21 0.16, 0.47 0.20 -0.64
aResults should be interpreted with caution due to inability of model to describe gas-uptake data.
bValues not reported due to skewness of results and influence ofoutliers.
*Statistically significantfor control vs. exposed; p<0.001 (as determined by studygroup).
**Statistically significant between age groups among controls; p< 0.05.
#Statistically significant between age groups among exposed; p < 0.05.
ranked two-way analysis of variance. Both
analyses gave, essentially, the same results.
Between-group post-tests were performed
using the Bonferroni adjustment for multi-
ple comparisons (27).
Results
BodyWeights, LiverWeights, and
Tumors Observed
The data on body and organ (liver and
lung) weights for the animals within the
pharmacokinetic studies are summarized in
Table 2. The mean body weight in the 1-
day mice was approximately 18 grams; it
peaked during the 12-month exposure
point at 38 grams before decreasing to 36
grams in the exposed mice at 24 months.
The organ weights at and beyond 12
months included the tumor masses.
Age- and Chronic Dosing-related
Pharmacokinetic Changes
Summary statistics for the optimized meta-
bolic constants are presented in Tables 3
and 4 and shown graphically in Figures 2
and 3. The model descriptions of the gas-
uptake data are illustrated in Figures 4 and
5. A nonparametric analysis of variance
revealed significant differences (p < 0.05)
among time points for the optimized meta-
bolic rate constants (Vm.c for mixed func-
tion oxidase pathway and Kfc for the glu-
tathione S-transferase pathway), as well as
significant differences between exposed and
control groups (p < 0.05). The apparent
Vmc and Kcvalues for the 1-day, 1-month,
1-year, and 2-year exposed groups are all
significantly different from those for the
concurrent control groups according to
between-group post-tests (p < 0.001); how-
ever, the 1-year metabolic data must be
interpreted with caution. The physiological
model was unable to adequately describe
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Figure 2. Age-related changes in the apparent
maximum metabolic rate for MFO pathway(VM,Xd}
for l36C3F1 mice exposed to 2000 ppm methylene
chloride and control mice. Data points represent
the median ± first and third quartiles for exposure
periods of 1 day, 1 month, and 2 years.
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fied and, more importantly, varied from
study group to study group. Therefore,
results of the optimized metabolic parame-
ters were summarized using the median and
interquartile ranges that are relatively stable
to the influences of the outliers. Statistical
analysis ofthe optimized metabolic parame-
ters were also performed using nonparamet-
ric statistics due to the non-normality ofdata
and differences in the distributions from
study group to study group. Changes in the
Vmaxj and Kfc among different age groups
were assessed with the Kruskal-Wallis non-
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the gas-uptake data, and all modeling
attempts to describe the gas-uptake data, at
the 1-year time point were poor within all
reasonable variations of physiological para-
meters. Experimentally, personnel, as well
as methods and materials, remained con-
stant throughout the 2-year period; there-
fore, we do not believe this anomally was
due to variability in techniques. Because
there were examples in which replicate
chronic toxicity studies yielded conflicting
results, we might be dealing with a larger
issue of the lack of homogeneity in the
experimental population, despite the use of
an inbred strain and proper randomization
processes.
Age-related differences in the median val-
ues for the control groups are also apparent
(Figs. 2 and 3). The apparent V.1.c is signifi-
candy greater in the 1-month control group
when compared with the 1-day control
group (p < 0.001), and the 2-year control
group is significantlylargerthan the 1-month
control group (p < 0.001). The same initial
increase exists in the exposed groups, but the
2-year exposed Vm.c is significantly smaller
than the 1-month group (p < 0.001). In con-
trast, age-related differences in the median
Kc show a decrease in both the 1-month
and2-year groups(p < 0.001) (Fig. 3).
Tissue Partition Coefficients in
Relation to Age and Exposure
Tissue partition coefficients determined at
various time points during the course ofthe
2-year study are summarized in Table 5.
According to a two-wayanalysis ofvariance,
significant differences with respect to treat-
ment were not found in the blood:air, mus-
cle:air, liver:air, or lung:air partition coeffi-
cients at p = 0.416, 0.087, 0.421, and
0.275, respectively. In contrast, previous
exposure to methylene chloride had a mar-
ginal effect in lowering the fat:air partition
m
cm -! 1.5
a.
a.
UC
I.
0C
UbO-
coefficient atp = 0.053, based on the analy-
sis ofvariance. Age-related differences were
found in musde:air, liver:air, lung:air, and
fat:air partition coefficients at p < 0.001
while the solubility of methylene chloride
in blood did not change (p = 0.461).
Between-group Bonferroni post-tests reveal
significant differences with respect to age.
Specifically, lung:air and fat:air partition
coefficients are significantly different
between the 1-day and 1-year groups (p <
0.05), as well as the 1-month and 1-year
groups (p < 0.05). All tissues, with the
exception ofblood, are statistically different
in the 2-year group as compared to the 1-
day, 1-month, or 1-year groups (p < 0.05).
It should be noted that tissue partition coef-
ficients for the 1-year time period appear to
conflict with the trends apparent in the sur-
rounding time periods. Similar difficulties
in describing the gas-uptake data at the 1-
year exposure period were also observed and
outlined in the previous section. Thus, the
1-year partition coefficient data should also
be interpretedwith caution.
Discussion
Computer Optimized Vm. andAqc
Values andTheir Significance
While previous PBPK studies have used
computer optimization routines for compar-
ing enzyme metabolic parameters in vivo, the
point estimates obtained by deterministic
techniques may not be representative of the
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actual values within a population and may
allow only limited statistical comparisons
between dose groups or controls (17,28,29).
Our study used Monte Carlo and bootstrap-
ping techniques in conjunction with com-
puteroptimization to reveal the rangeofpos-
sible values for these metabolic parameters,
given the intraspecies variability within the
study group. A word of caution must be
emphasized in avoiding overindulgence in
the utility ofthe present approach ofPBPK
modeling/Monte Carlo simulation.
Statistical significance is directly related to
the size ofthe sample and, in our study, the
number of simulations. Therefore, by
increasing the number of simulations, it is
possible to increase the statistical significance
of two comparison groups beyond that of
practical significance. For example, the dif-
ference between the median 2-year exposed
(8.68) and median 2-year control (9.31)
groups for Vmac was found to be statistically
significant (p < 0.001). While the difference
is not necessarily artifactual, a difference of
0.63 would not maintain a practical signifi-
cance in conventional toxicology studies.
Nonetheless, with the possible exception of
the 1-year comparisons for exposed and con-
trol groups, the remaining values in our
study were different from both practical and
statistical standpoints.
Significant increases in Vm.c were seen
at the 1-day and 1-month exposure points
when compared to controls and may repre-
sent an initial induction ofthe MFO path-
2 3 4 5 5
Age ofmice(days)
Figure 3. Age-related changes in apparent first-
order GST metabolism (Kfr) for B6C3F1 mice
exposed to 2000 ppm methylene chloride and con-
trol mice. Data points representthe median ± first
and third quartiles for exposure periods of 1 day, 1
month, and 2years.
Time (hr)
Figure 4. Final gas-uptake pharmacokinetic curves of control B6C3F1 mice used to estimate the kinetic
constants for the MFO and GST pathways. Data show the concentration of methylene chloride (ppm) in
the chamber atmosphere as a function of time. Experimental data are shown as symbols while the com-
puter model simulation is presented as a solid line.
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way (Table 3 and Fig. 2). The extent ofthe
Vmaxc increase in the 1-day treated animals
(6.44) when compared to controls (4.53)
reveals a relatively rapid time course of
induction for methylene chloride. As a
comparison, phenobarbital and 3-methyl-
cholanthrene are known to produce maxi-
mal induction at approximately 4 days and
48 hours, respectively (30). The difference
in Vmaxc was maintained in the 1-month
time period and reversed in the 2-year
0.-
Q
0.
=
CJ
U
@2
:0.
'S.
exposure group; this suggests that the ini-
tial induction of MFO activity was main-
tained as long as 1 month following the
beginning of exposure. Because the mice
were 4 to 6 weeks ofage on arrival, the rel-
atively large difference in control and
exposed mice at the 1-day and 1-month
exposure points is attributed to the high
rate of de novo protein synthesis found in
relatively young mice. At the 2-year expo-
sure periods, de novo protein synthesis is
.0
o
O 1 2 3 4 5 6 0
Time (hr)
Figure 5. Final gas-uptake pharmacokinetic curves of exposed B6C3F1 mice used to estimate the kinetic
constants for the MFO and GST pathways. Data show the concentration of methylene chloride (ppm) in
the chamber atmosphere as a function of time. Experimental data are shown as symbols while the com-
puter model simulation is presented as a solid line.
Table 5. Tissue partition coefficients of methylene chloride from female B6C3F1 mice in relation to age
and exposurea,b
Study group Blood Fatc Muscle Lung Liver
1 day Control 26.0 ± 2.1 110 ± 11 14.1 ± 1.6 17.0 ± 1.8 18.6 ± 2.2
Exposed 27.2 ±3.2 106 ±4 14.4 ±2.8 17.7 ±3.5 19.5 ±0.4
Averaged 26.6 108* 14.2* 17.4* 19.0*
1 month Control 26.4 ±3.3 115 ± 10 13.7 ± 2.4 16.5 ±4.0 17.4 ± 2.6
Exposed 25.0 ± 1.3 108 ± 6 13.5 ± 2.1 16.8 ± 3.1 18.2 ± 2.1
Average 25.7 112* 13.6* 16.6* 17.8*
1 year Control 24.7 ± 0.7 103 ± 4 13.6 ± 1.8 20.2 ± 1.0 17.9 ± 2.5
Exposed 25.1 ± 1.5 102 ± 2 14.1 ± 1.8 23.1 ± 3.4 18.0 ± 1.6
Average 24.9 102* 13.8* 21.6** 18.0*
2year Control 25.6 ±0.6 124 ±4 22.9 ±2.6 11.6 ±1.3 13.6 ±1.2
Exposed 27.7 ±0.4 117 ±3 27.2 ± 1.7 12.1 ±0.9 13.9 ±0.9
Average 26.6 120** 25.0** 11.8# 13.8**
aMean ± SD.
bAccording to a two-way analysis of variance, age related diferences were found in muscle, liver, lung,
and fat at p< 0.001.
cAccording to a two-way analysis ofvariance, previous exposure to methylene chloride had a significant
effect on its solubility in fat atp = 0.053.
dAverage of control and exposed groups included to observe trend with age.
*,**,#Significant (p < 0.05) differences between age groups as determined by Bonferroni between-group
post-tests: all groups with a column with the same symbol are notsignificantly different, but groups with dif-
ferentsymbols are significantly different.
significantly reduced and the toxic effects
ofcontinuous exposure to methylene chlo-
ride may be exerting itself.
Age-related changes in Vma. within con-
trol and exposed groups were also observed.
In control animals, Vmx increased approxi-
mately61% between the 1-dayand 1-month
groups and 106% between the 1-day and 2-
year groups. A similar increase was observed
in exposed groups between the 1-day and 1-
month mice, followed by a decrease in the 2-
year animals. As previously reported, methyl-
ene chloride metabolism via the MFO path-
way occurs predominantly through the
P4502E1 isozyme (31), and similarage-relat-
ed changes in P4502E1 activity have been
reported elsewhere (32-34). Using 7-ethoxy-
coumarin as a substrate for cytochrome
P4502E1 (35), Stohs et al. (32) reported a
near 3-fold increase in liver 2E1 activity for
female Swiss Webster mice between the ages
of 1 month and 9 months; this increase was
followed by a gradual decline in activity out
to 18 months. Lung P4502E1 activity
showed a similar age-related change with a
peak at 6 months (32); however, in a limited
study of only 12-month and 24-month-old
female C3B10RF1 mice, Koizumi et al. (33)
found no significant change in P4502E1
activitywith age.
Although differences in the GST-
dependent pathway were also observed
between control and treated mice, the gas-
uptake system is not extremely sensitive to
changes in Kf (2), and drawing conclusions
as to the meaning of these differences are
tenuous. Nevertheless, there appear to be
consistent decreases in apparent kIc within
exposure groups (Fig. 3) and in the appar-
ent Kfc of the exposed mice in the 1-day
and 1-month groups relative to the controls
(Table 4). In the literature, support for a
change in GST metabolism with age is
inconsistent and depends on the substrate,
sex, and strain involved. Studies by Carrillo
et al. (36) in female C57 black mice reveal a
decline in basal GST activity using 1,2-
dichloro-4-nitrobenzene (DCNB) as a sub-
strate, while activity toward 1-chloro-2,4-
dinitrobenzene (CDNB) remains relatively
constant. Substrate specificity for DCNB is
related to GST MIII (class mu) (37), which
suggests a decline in this isozyme with age.
Other studies by Egaas et al. (38) reveal an
age-dependent increase in GST MI (class
alpha) activity between late adolescent
C57BL/6 mice (44 days old) and sexually
mature mice (88 days old) while female
DBA/2 mice showed a decline in GST MII
(class pi) activity. For methylene chloride
metabolism, the GST class theta has been
identified as the primary. isozyme in
humans and rats (39); however, no infor-
mation in the literature was found on the
Environmental Health Perspectives * Volume 104, Number8, August 1996
S
863Articles * Thomas et al.
change in GST class theta activitywith age.
The changes in apparent Kfc due to
prior exposure are also without precedence
in the literature. Green (6) reported exten-
sive vacuolation ofthe smooth endoplasmic
reticulum (SER) of the Clara cells in the
lungs ofmale B6C3F1 mice following a sin-
gle inhalation exposure of methylene chlo-
ride at 4000 ppm; however, after 10 days of
continuous exposure, the vacuolation was
no longer apparent. Concurrent enzyme
profile studies revealed the remarkable
effect that cytochrome P450 metabolism of
methylene chloride decreased by about
50% in lung microsomes in both the 1-day
and 10-day exposed mice, whereas GST
metabolism remained unchanged in the
lung cytosolic fraction (6). In our study, the
exposure level was 2000 ppm methylene
chloride, and whether similar effects on
Clara cells in the lung existed remains
unknown. Since lung metabolism ofmeth-
ylene chloride represents only a small frac-
tion of the overall metabolism, any time-
course and exposure-related changes that
may have occurred would have been totally
masked by the predominance of liver
metabolism in our in vivo pharmacokinetic
studies. Nevertheless, in considering the
carcinogenic effects of methylene chloride,
such organ specific time-course and expo-
sure-related pharmacokinetic changes are of
utmost importance.
Changes inTissue Partition
Coefficients withAge and Exposure
While prior exposure to methylene chloride
produced only a marginal difference in the
fat:air partition coefficient atp = 0.053, the
effect of treatment resulted in a consistent
reduction (-5%) in the fat:air partition
coefficient in all exposure time points, with
the exception ofthe 1-year group (Table 5).
However, this reduction may be somewhat
artificial and might be attributed to the
headspace analysis used to determine parti-
tioning. When partition coefficients are
measured in vitro, a known amount of
methylene chloride is injected into a closed
vial containing a known amount of tissue.
Following equilibration, the headspace is
then analyzed for methylene chloride while
the amount in the tissue is inferred from
subtraction. Therefore, if animals were
exposed to methylene chloride prior to sac-
rifice and a significant quantity of methyl-
ene chloride remained in the fat, the parti-
tion coefficient may be artificially reduced
because the total quantity of methylene
chloride in thevial and tissue is greater than
the known amount added to determine par-
titioning. Fortunately, this phenomenon
produced only a marginal effect in the fat
tissue and had no significant effect in the
other tissues studied. In retrospect, one pos-
sible solution to this problem may be to
measure methylene chloride concentrations
in both the tissue and the headspace.
Age-related differences in solubility
were observed in the muscle, liver, lung,
and fat tissues, while the blood:air partition
coefficients maintained no signiflcant
change with age. These results are consis-
tent with the physiological changes that
occur in the majority of tissues during the
aging process. The fat:air partition coeffi-
cients, when averaged across exposure
groups (Table 5), maintain a consistent
increase in partition coefficient as a func-
tion of age, with the exception of the 1-
year time period. While the specific mecha-
nism behind the increase in fat:air partition
with age is unknown, physiological changes
in fat structure (i.e., changes in fat steroid
concentration and changes in fat morphol-
ogy) (40,41) remain alikelyexplanation.
Changes in the average muscle:air parti-
tion coefficient with age can also be
explained in physiological terms. While no
significant differences in the muscle:air par-
tition coefficients were found between the
1-day and 1-month mice (p < 0.05), a sig-
nificant increase in solubility was found
between the 1-day and 2-year groups
(Table 5). This difference might be attrib-
uted to the increase in adipose content of
muscle fibers with age, which would result
in larger partition coefficients. Conversely,
organs such as the lung and liver maintain
a higher connective tissue mass (collagen)
per unit volume with age (42). As a result,
solubility would potentially decrease as a
function of age. Results from our study
support this hypothesis and reveal a consis-
tent decrease in liver and lung solubility in
the 1-day, 1-month, and 2-year exposure
groups (Table 5).
Applications to RiskAssessment
Although significant effort has been put
forth to characterize the disposition and
metabolism associated with methylene chlo-
ride in young healthy animals (3,43,44),
age-related changes in MFO and GST
activity, as well as in physiological parame-
ters, may be more important from a risk
assessment perspective. According to
Andersen et al. (3), the dose surrogate cal-
culated from the amount metabolized by
the GST pathway can be directly related to
the carcinogenic risk ofmethylene chloride
exposure; therefore, any physiologic or
metabolic changes that result in an increase
or decrease in the dose surrogate will direct-
ly impact the risk of methylene chloride-
induced carcinogenesis. For example, the
net effect ofthe increase in apparent Vm:
between the 1-day and 2-year groups, while
holding KfC constant, results in 18%
decrease in the GST dose surrogate to both
liver and lung. Furthermore, any decrease
in the apparentKfc with age would result in
an additional and more dramatic decrease
in the dose surrogate.
Age-related changes in disposition may
also assist in interpreting the concurrent
long-term carcinogenicity study for methyl-
ene chloride, which included various expo-
sure regimens and stop exposures (8).
Specifically, these studies revealed relatively
high incidences of hepatocellular and pul-
monary adenomas/carcinomas when meth-
ylene chloride was administered for dura-
tions of26, 52, and 78 weeks prior to expo-
sure to uncontaminated airfor a total of104
weeks (8). In contrast, relatively low inci-
dences of hepatocellular and pulmonary
ademonas/carcinomas were observed in
mice when uncontaminated air was admin-
istered for the identical durations prior to
methylene chloride (8). Although not con-
clusive, these changes in tumor incidence
correlate well with ashift in methylene chlo-
ride metabolism toward the MFO pathway
with increasing age and suggest that age at
exposure may be an important risk factor in
methylene chloride-induced carcinogenesis.
In conclusion, age and prior exposure
to methylene chloride can produce notable
changes in disposition and metabolism and
may represent important factors in the
interpretation of toxicologic and pharma-
cokinetic data. For methylene chloride
specifically, further study is needed for age-
related changes in GST metabolism for
both interpretation of animal studies and
identification ofrisk to humans.
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